News

Filter

Current filters:

Natrecor

1 to 9 of 81 results

J&J unit Scios pleads guilty to misbranding Natrecor, paying $85 million fine

07-10-2011

Scios, a subsidiary of US health care giant Johnson & Johnson (NYSE: JNJ), has pleaded guilty tto a misdemeanor…

Cardio-vascularJohnson & JohnsonLegalNatrecorNorth AmericaPharmaceuticalScios

Heart meeting hears disappointing results for J&J/Scios Natrecor; strong findings for Pfizer’s Inspra

15-11-2010

Studies presented at the American Heart Association conference taking place in Chicago, showed that people…

Cardio-vascularInspraJohnson & JohnsonNatrecorPfizerPharmaceuticalResearchScios

ARCA renames to reflect new focus

07-04-2008

Denver, USA-based ARCA Discovery, a privately-held company, has changed its name to ARCA biopharma, effective…

Antihemophilic FactorCoagulation Factor VIIaJohnson & JohnsonNatrecorNesiritideRecombinant

J&J subsids receive three US subpoenas

19-03-2007

Global health care giant Johnson & Johnson says that it has received three separate subpoenas from the…

infliximabJohnson & JohnsonNatrecorNesiritideRemicadeRisperdalRisperdal ConstaRisperidoneTopamaxtopiramate

J&J's Scios reports new Natrecor deaths

09-01-2006

Johnson & Johnson subsidiary Scios has submitted an interim report to the US Food & Drug Administration,…

Johnson & JohnsonNatrecorNesiritide

1 to 9 of 81 results

COMPANY SPOTLIGHT

Menarini

Back to top